Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04181775 · ClinicalTrials.gov registry record

Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)

A clinical trial, sponsored by Methodist Health System.

Completed
Registry status
471
Enrollment target

NCT04181775 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 471 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04181775 has completed, sponsored by Methodist Health System.

COMPLETED
Registry status
471 participants
Enrollment target

Study Summary

The rationale for this study is to evaluate the effectiveness of a risk prediction tool for patients who are at high risk for ADEs resulting in hospitalization or ED revisit. The ADE-RED score initiates a PLMR that literature has shown reduces medication discrepancies and ADEs at hospital admission and discharge. No current system identifies patients presenting to the ED that may benefit from PMLR independent of an admission disposition. The ADE-RED scoring tool will reduce the incidence of future visits to the ED or future admissions by identifying patients who are at high risk for ADE-related readmissions.

Interventions

  • DIAGNOSTIC_TEST ADE-RED scoring tool

Trial Details

FieldValue
Enrollment Target 471 participants
Start Date 2019-11-08
Est. Completion 2020-06-22

Sponsor

Methodist Health System

125 total trials

What the Registry Record Tells You About NCT04181775

The ClinicalTrials.gov registry entry for NCT04181775 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ADE-RED scoring tool is the first listed.

NCT04181775 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04181775 about?

NCT04181775 is a clinical study titled "Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)". The rationale for this study is to evaluate the effectiveness of a risk prediction tool for patients who are at high risk for ADEs resulting in hospitalization or ED revisit. The ADE-RED score initiates a PLMR that literature has shown reduces medication discrepancies and ADEs at hospital admission ...

What is the current status of trial NCT04181775?

This trial is currently completed. The enrollment target is 471 participants. The study started on 2019-11-08. Estimated completion is 2020-06-22.

What interventions are being tested in trial NCT04181775?

The interventions under investigation include: ADE-RED scoring tool (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04181775?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.